ZURICH A scientist investigating rare blood clots possibly linked to AstraZeneca's and Johnson & Johnson's COVID-19 vaccines has yet to start a planned collaboration with the U.S. company, he said, as talks over their research pact continue.
WALD/DAVOS, Switzerland (Reuters) -Swiss mountain sanatoriums whose fresh-air and sunlight cures once drew tuberculosis patients from across Europe are reinventing themselves for a new generation: Patients suffering from the lingering effects of COVID-19.
* Approach contrasts with U.S., UK long COVID outpatient therapy
BRUSSELS The European Union has secured about 55,000 doses of a potential treatment for COVID-19 based on a cocktail of monoclonal antibodies developed by U.S. drugmaker Regeneron and Swiss pharmaceutical giant Roche, an EU spokesman said.
ZURICH Men with a deadly form of advanced prostate cancer who failed other treatments survived four months longer after getting an experimental, tumour-targeting radiation therapy from Swiss drugmaker Novartis, data released on Thursday showed.
GENEVA/ZURICH (Reuters) -Countries and private donors pledged nearly $2.4 billion on Wednesday to the COVAX vaccine-sharing plan, expanding efforts to make COVID-19 shots more available to people in poorer nations.
ZURICH (Reuters) -Moderna is gearing up to halve the dose of its COVID-19 vaccine, the U.S. drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children.
ZURICH (Reuters) -International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.
Israel condemned on Sunday the election of hardline judge Ebrahim Raisi as Iranian president, saying his would be a "regime of brutal hangmen" with which world powers should not negotiate a new nuclear deal.